✦ LIBER ✦

Graft versus host disease following allogeneic bone marrow transplantation

✍ Scribed by Nelson J Chao

Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 781 KB
Volume: 4
Category: Article
ISSN: 0952-7915
DOI: 10.1016/0952-7915(92)90028-d

No coin nor oath required. For personal study only.

✦ Synopsis

Graft versus host disease is a major barrier in allogeneic bone marrow transplantation. The associated morbidity and mortality need to be understood and prevented if possible, as the potential indications for bone marrow transplantation continue to broaden. Areas of investigation include the cellular effector arm as well as the cytokines associated with the expression of the disease.

📜 SIMILAR VOLUMES

Adjusted-dose continuous-infusion cyclos

Adjusted-dose continuous-infusion cyclosporin A to prevent graft-versus-host disease following allogeneic bone marrow transplantation

✍ K. B. Miller; D. P. Schenkein; R. Comenzo; J. K. Erban; T. Fogaren; C. A. Hirsch 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 654 KB

Expression of CD134 (0X-40) on T cells d

Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease

✍ L.S. Lamb Jr; S.A. Abhyankar; L. Hazlett; W. O'Neal; R.S. Folk; S. Vogt; R.S. Pa 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

## CD134 (OX-40 ) is an activation-associated antigen which functions as a costimulatory receptor for CD4؉ T cells. In order to determine the expression of CD134 during immune recovery following allogeneic bone marrow transplantation (BMT), we measured its expression on T cells and T cell subsets

Graft-versus-host disease following inte

Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived

✍ Brian J. Boughton; Andrew W. Simpson; Trevor A. J. Phaure; Cynthia Beatty 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 638 KB

Antiphospholipid syndrome complicating c

Antiphospholipid syndrome complicating chronic graft-versus-host disease after allogeneic bone marrow transplantation

✍ D. Söhngen; A. Heyll; G. Meckenstock; C. Aul; H.-H. Wolf; W. Schneider; C. Speck 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 2 views

Orthotopic liver transplantation for acu

Orthotopic liver transplantation for acute grade IV hepatic graft-versus-host disease following bone marrow transplantation

✍ Figuera, Angela; Tomás, José F.; Otero, Mariá J.; Moreno, Enrique; García, Ismae 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 2 views

Naevi in allogeneic bone marrow transpla

Naevi in allogeneic bone marrow transplantation recipients: the effect of graft-versus-host disease on naevi

✍ V. Andreani; M.A. Richard; D. Blaise; J. Gouvernet; J.J. Grob 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

## Background: Non-melanoma skin carcinoma is more common in transplant recipients, probably because of immunosuppression. an increased risk of developing melanoma could be a late effect of transplantation. the number of naevi, which is a risk marker for melanoma, is increased in renal transplant r